Datametrex AI Limited, formerly Everfront Ventures Corp, is a software technology company that primarily focuses on data management and delivering information solutions.
It is a publicly listed company on the TSX Venture Exchange with common stocks trading under ‘DM’ symbol. The Toronto-based company also trades its common stocks on the OTCQB Market in the United States with the ‘DTMFX’ symbol. In addition, the tech company is also listed on the Frankfurt Stock Exchange (FSE), where the trading symbol is ‘D4G’.
Datametrex uses artificial intelligence and machine learning to capture, analyze and present refined and non-refined data that brief the clients about the market trends and new opportunities associated risks, enabling them to make informed decisions.
The technology company collects, and processes structured and unstructured data from social media platforms like Facebook, Google alerts, online news sites, online blogs and forums, Twitter, etc. The firm says that at presents its AI system supports data in four languages: English, Korean, Russian and French.
The company operates its artificial intelligence and machine learning operations through Nexalogy, a 100 per cent owned subsidiary that provides two tools, NexaAgent and NexaIntelligence.
NexaIntelligence extracts important information from large data and gives conclusive synthesis, including crucial terminology. In addition, the NexaAgent is an integrated tool for data mining and augmenting analysis by NexaIntelligence, optimized for various devices, including mobiles, laptops, tablets, etc.
Datametrex claims to provide advanced AI-based tools to support the supply chain of COVID-19 Test Kits, including, Nucleic Acid Detection Kits (in Canada), Antigen Detection Kits and Antibody detection Kits (only available in specific jurisdictions, including the United States and European Union).
The company in April 2021 claims to have completed more than 30,000 PCR tests for the film and production industry in Montreal, Toronto, and Vancouver.
On April 26, 2021, Datametrex entered into a partnership agreement with ScreenPro Security Inc for the COVID-19 test process. In the following month, the software firm secured an additional AI & Tech contract from three LOTTE Group and Shinhan Financial Group with an order value of C$550,000.
The Canadian technology firm acquired a British Columbia-based telemedical firm, Medi-Call Inc, in June 21, 2021, through a share exchange agreement. Following the transaction, the telemedical firm now operates as a wholly owned subsidiary of Datametrex.